IL6 and neoplasm: In CD8+ T cells, IL6 upregulates immune checkpoints like PD-1, diminishing cytotoxic function and reducing the production of key cytokines, such as interferon-gamma (IFN-γ), thereby impairing anti-tumor responses [55].